Parliament negotiators agreed on a deal with member states to significantly step up the EU’s action in the health sector through a dedicated 5.1 billion EUR "EU4Health Programme" as part of the EU’s recently agreed long-term budget.
The intent of this work is to speed up drug repurposing, which is not a new concept - think Botox injections, first approved to treat crossed eyes and now a migraine treatment and top cosmetic strategy to reduce the appearance of wrinkles.